Drew T Bergman
Drew T Bergman
Geisel School of Medicine at Dartmouth, Broad Institute of MIT and Harvard
Verified email at - Homepage
Cited by
Cited by
Activity-by-contact model of enhancer–promoter regulation from thousands of CRISPR perturbations
CP Fulco, J Nasser, TR Jones, G Munson, DT Bergman, V Subramanian, ...
Nature genetics 51 (12), 1664-1669, 2019
Genome-wide enhancer maps link risk variants to disease genes
J Nasser, DT Bergman, CP Fulco, P Guckelberger, BR Doughty, ...
Nature 593 (7858), 238-243, 2021
Compatibility rules of human enhancer and promoter sequences
DT Bergman, TR Jones, V Liu, J Ray, E Jagoda, L Siraj, HY Kang, ...
Nature 607 (7917), 176-184, 2022
Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features
JP Ray, CG de Boer, CP Fulco, CA Lareau, M Kanai, JC Ulirsch, ...
Nature communications 11 (1), 1237, 2020
HyPR-seq: Single-cell quantification of chosen RNAs via hybridization and sequencing of DNA probes
JL Marshall, BR Doughty, V Subramanian, P Guckelberger, Q Wang, ...
Proceedings of the National Academy of Sciences 117 (52), 33404-33413, 2020
Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi
ME Muse, DT Bergman, LA Salas, LN Tom, JM Tan, A Laino, D Lambie, ...
Journal of Investigative Dermatology 142 (7), 1893-1902. e7, 2022
Mapping the convergence of genes for coronary artery disease onto endothelial cell programs
GR Schnitzler, H Kang, VS Lee-Kim, RX Ma, T Zeng, RS Angom, S Fang, ...
bioRxiv, 2022.11. 01.514606, 2022
The system can't perform the operation now. Try again later.
Articles 1–7